Throughout the last three months, 4 analysts have evaluated CollPlant Biotechnologies (NASDAQ:CLGN), offering a diverse set of opinions from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 4 | 0 | 0 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 2 | 0 | 0 | 0 | 0 |
| 2M Ago | 0 | 0 | 0 | 0 | 0 |
| 3M Ago | 1 | 0 | 0 | 0 | 0 |
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $12.5, along with a high estimate of $14.00 and a low estimate of $11.00. This current average reflects an increase of 4.17% from the previous average price target of $12.00.
Deciphering Analyst Ratings: An In-Depth Analysis
The standing of CollPlant...
Login or create a forever free account to read this news
Sign up/Log in
